Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors
DOI
オープンアクセス
この論文をさがす
収録刊行物
-
- Future Oncology
-
Future Oncology 20 1069-1077, 2024-01-12
Informa UK Limited
